A 3-Mb High-Resolution BAC/PAC Contig of 12q22 Encompassing the 830-kb Consensus Minimal Deletion in Male Germ Cell Tumors by Vundavalli, Murty V. et al.
A 3-Mb High-Resolution BAC/PAC Contig
of 12q22 Encompassing the 830-kb Consensus
Minimal Deletion in Male Germ Cell Tumors
Vundavalli V.V.S. Murty,1,5 Kate Montgomery,2 Shipra Dutta,1 Shashi Bala,1
Beatrice Renault,2 George J. Bosl,3 Raju Kucherlapati,2 and Raju S.K. Chaganti4
1Department of Pathology, College of Physicians & Surgeons of Columbia University, New York, New York 10032 USA;
2Department of Molecular Genetics, Albert Einstein College of Medicine, Bronx, New York 10461 USA; 3Department of
Medicine, and 4Laboratory of Cancer Genetics & Department of Human Genetics, Memorial Sloan-Kettering Cancer Center,
New York, New York 10021 USA
Cytogenetic and molecular genetic analyses have shown that the 12q22 region is recurrently deleted in male
germ cell tumors (GCTs), suggesting that this site may harbor a tumor suppressor gene (TSG). Previous loss of
heterozygosity (LOH) analyses identified a consensus minimal deleted region between the markers D12S377 and
D12S296, and a YAC clone contig covering the region was generated. Here, we describe a high-resolution
sequence-ready physical map of this contig covering a 3-Mb region. The map comprised of 52 cosmids, 49
PACs, and 168 BACs that were anchored to the previous YAC contig; 99 polymorphic, nonpolymorphic, EST,
and gene-based markers are now placed on this map in a unique order. Of these, 61 markers were isolated in the
present study, including one that was polymorphic. In addition, we have narrowed the minimal deletion to
~ 830 kb between D12S1716 (proximal) and P382A8-AG (distal) by LOH analysis of 108 normal-tumor DNAs from
GCT patients using 21 polymorphic STSs. These physical and deletion maps should prove useful for
identification of the candidate TSG in GCTs, provide framework to generate complete DNA sequence, and
ultimately generate a gene map of this segment of the chromosome 12.
[The sequence data described in this paper have been submitted to the Genome Survey Sequence under
accession nos. AQ254896–AQ254955 and AQ269251–AQ269266. Online supplementary material is available
at http://www.genome.org]
Recurrent cytogenetic aberrations affecting both the
short and the long arms of chromosome 12 are a char-
acteristic feature of male germ cell tumors (GCTs)
(Chaganti et al. 1996). Extensive cytogenetic and mo-
lecular genetic studies of male GCTs identified genetic
alterations on chromosome 12q. Cytogenetic studies
demonstrated subregional deletions or monosomy of
12q in a high proportion of cases (Murty et al. 1990;
Samaniego et al. 1990; Rodriguez et al. 1992). At the
molecular genetic level, restriction fragment length
polymorphism (RFLP) analysis identified loss of het-
erozygosity (LOH) at two sites, 12q13 and 12q22, sug-
gesting the presence of at least two candidate tumor
suppressor genes (TSGs) (Murty et al. 1992). LOH
analysis of 12q22 revealed allelic loss in 51% of tumors
and a homozygous deletion in one tumor further sup-
ported this view (Murty et al. 1992). The minimal de-
leted region was subsequently localized between the
markers D12S1716 and D12S346 (Murty et al. 1996).
We also constructed a detailed physical map of the
region by identifying contiguous mega YAC clones
covering the minimal deleted region and generated a
radiation hybrid map (Murty et al. 1996). To facilitate
the isolation of candidate TSG(s), in the present study,
we developed a 3-Mb sequence-ready contig map con-
sisting of BACs, PACs, and cosmids of the region of
12q22 that includes the minimal deletion. We were
further able to narrow the deletion interval to an 830-
kb region by LOH analysis of additional normal-tumor
paired DNAs using new polymorphic markers. This
study represents generation and mapping of 61 new
STSs, including one polymorphic marker, as well as
placing of several known ESTs and genes in the contig.
The new map that we present will comprise the frame-
work to generate a complete DNA sequence of the re-
gion and forms a basis for identification of the candi-
date TSG(s) in GCT.
RESULTS
Construction of a 3-Mb BAC, PAC,
and Cosmid Contig at 12q22
We previously generated a YAC contig map defined by
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the interval D12S101 proximally and D12S346 distally.
This map consisted of 53 clones and included deleted
region onto which 25 STS markers were ordered (Murty
et al. 1996). These STSs served as the framework in
generating the cosmid, PAC, and BAC clone contig de-
scribed here. Initial screening was performed with 10
known nonpolymorphic STSs and STSs designed from
the published sequences of polymorphic markers
(GCT8BO7, D12S1300, D12S1671, D12S296) (Murty et
al. 1996; Kucherlapati et al. 1997). This screening re-
sulted in the isolation of eight clone clusters of cos-
mids, PACs, and BACs anchored to the framework map
with large gaps between them. In the initial phase of
contig construction PAC and BAC clones were more
successfully linked with adjacent loci than cosmids.
Therefore, subsequent screening and contig expansion
was restricted to PAC and BAC libraries. A bidirectional
chromosome walk was initiated from these clone is-
lands in which appropriate clone ends were sequenced,
and new STSs, which were used as probes to rescreen
libraries, were generated. New clones identified in this
manner were placed on the map by PCR analyses. After
several rounds of screening, this strategy allowed us to
generate a complete high-density map of the region
consisting of cosmids, PACs, and BACs (Fig. 1). A total
of 269 clones (52 cosmids, 49 PACs, and 168 BACs)
were placed in the present contig, which span a 4-cM
genetic distance (Dib et al. 1996) between SHGC-33859
(HAL) (proximal) and D12S1100 (distal) (Fig. 1). To
complete the contig by linking these clones, sequences
from 76 cosmid, PAC, and BAC ends were generated
(sequence data submitted to Genome Survey Sequence;
accession nos. AQ254896–AQ254955, AQ269251–
AQ269266). This sequence information enabled us to
design primers for new STSs, and a total of 61 STSs were
mapped back to the contig (Table 1; Fig. 1). These STSs
included a dinucleotide polymorphic marker, P382A8-
AG. All of the newly generated STSs were also mapped
by STS-content analysis onto the YAC clones in the
contig. This enabled us to anchor cosmid, PAC, and
BAC clones to the YAC contig and the genetic map.
The clone coverage obtained for the markers in the
map ranged between 2 (D12S1082 ) and 28
(D12S1218E). Eleven clones containing D12S1100 at
the extreme telomeric end of the YAC contig have
been included although they were not connected with
the PAC/BAC contig.
Mapping of ESTs and Genes to 12q22 Physical Map
A total of 36 ESTs within the genetic interval of 101–
106 cM were identified from databases of human
physical and transcript maps. The ESTs were first PCR
amplified on pooled YAC clones covering the minimal
tiling path; however, only 13 of them mapped within
the YAC contig. The individual YAC, BAC, PAC, and
cosmid clones were then analyzed by PCR for STS con-
tent using these 13 ESTs to determine their precise map
positions (Fig. 1). Of these, one EST (WI-17759) was
mapped within the previously defined minimal de-
leted region in GCTs (Murty et al. 1996) and the re-
maining were mapped outside. Among the 13 ESTs,
eight represented five known genes. These included
histidine ammonia-lyase (HAL, SHGC-33859), ETS-
domain protein ELK3 (ELK3/Z36715), human thymo-
poietin (TMPO, WI-11271), phosphate carrier mito-
chondrial (PHC, D29485) and apoptotic protease acti-
vating factor (APAF1). The HAL, ELK3 (NET3), PHC,
and TMPO genes were previously mapped in the YAC
contig (Murty et al. 1996; Kucherlapati et al. 1997). The
TMPO gene was previously mapped to 12q22 by FISH
(Harris et al. 1995). APAF1 was identified through
BLAST search of P373G19-T7 end. The HAL and ELK3
genes were mapped proximal, whereas TMPO, PHC,
and APAF1 were mapped distal to the consensus-
deleted region (Fig. 1).
Refinement of the Minimal Deleted Region
Between D12S1716 and P382A8-AG
Expecting that new polymorphic markers might help
narrow the minimal deletion further, we identified six
dinucleotide repeats from the BAC, PAC, and cosmid
end sequences. We designed primers flanking a dinuce-
lotide (AG)n repeat from P382A8 clone end (accession
no. AQ254947) that was mapped in the previously
identified region of minimal deletion. We were unable
to design primers from others because of flanking Alu
repeats. On testing of a panel of 91 normal DNAs,
P382A8-AG exhibited heterozygosity in 76 (83%). We
previously defined the minimal deleted region be-
tween the markers D12S1716 proximally and D12S346
distally with an estimated size of 1.7 Mb based on LOH
analysis of 67 normal-tumor GCT DNAs using 18 poly-
morphic markers. These tumors were now analyzed for
LOH with three additional markers (GCT8BO7,
D12S1671, P382A8-AG) (Table 2). In the present study,
we also analyzed an additional panel of 41 normal-
tumor GCT DNAs for LOH using all 21 polymorphic
markers. Among the 108 DNAs analyzed, 52% (56
cases) showed LOH at one or more loci. Of these, 27
cases were uninformative in defining the deletion as
they either showed LOH at all informative loci or ex-
hibited microsatellite instability. The remaining 29
cases had deletions at one or more loci that were
within the consensus region of loss, while retaining
heterozygosity at the flanking loci. These 29 tumors
with partial deletions were used in further defining the
minimal region of deletion. The pattern of LOH among
them identified a consensus region of deletion with
boundaries defined by retention of heterozygosity in at
least two tumors and LOH at interstitial markers (Fig. 2
and online Fig. 3). The revised minimal deletion in-
cluded four polymorphic markers D12S377, GCT8BO7,
























D12S1051, and D12S1657 flanked by the marker
D12S1716 proximally (T-362A, T-167A, T-344A) and
P382A8-AG distally (T-225A, T-225B, T-167A, T-320A)
(Fig. 2 and online Fig. 3).
Comprehensive Physical Map and Estimation of Sizes
of the Contig and the Minimal Deletion
The combination of mapping of STSs, ESTs, and gene-
based markers resulted in the construction of a com-
plete BAC, PAC, and cosmid clone contig covering a
genetic distance of 4 cM (Fig. 1). This integrated contig
map comprised of 42 YACs, 168 BACs, 49 PACs, and 52
cosmids. A total of 99 STS markers have been ordered
in the contig, which included 14 polymorphic STSs, 72
nonpolymorphic STSs, 8 ESTs, and 5 genes. To validate
the contig generated by STS-content mapping, we per-
formed HindIII restriction fragment fingerprint analy-
sis of 85 BAC and 2 PAC clones, which provided at least
double coverage between markers SHGC-33859 and
D12S1082 (Fig. 1). Analysis of the fingerprints allowed
us to verify the integrity of this set of clones in the
minimal tiling path. FISH analysis of 13 BACs and 1
PAC confirmed the position of these clones to 12q22
(data not shown). The size of the BAC/PAC-contig be-
tween SHGC-33859 and D12S1082 was estimated from
the clones contained within the minimal tiling path.
The estimate is based on an average insert size of 177
kb for the BAC clones in this library (http://bacpac.
med.buffalo.edu/). The minimal tiling path consists of
22 BAC clones. Based on this, the total size of these
clones is estimated to be 3894 kb (177 2 22). The
minimal tiling path comprised 132 markers with 34
overlapping, suggesting a 25% overlap. Thus, the size
of the contig at 75% is estimated to be 2920 kb. There-
fore, the average marker resolution in the contig is 30
kb. In a similar evaluation, the minimal deleted region
between the markers D12S1716 and P382A8-AG was
estimated as 830 kb.
DISCUSSION
We previously identified a candidate TSG site at 12q22
in male GCTs characterized by frequent cytogenetic
deletion (Murty et al. 1990; Samaniego et al. 1990;
Rodriguez et al. 1992) and LOH (Murty et al. 1992,
1996). The LOH analysis also identified a 3-cM com-
mon minimal region of deletion between the markers
D12S377 and D12S296, which was estimated to be 1.7
Mb, based on the YAC contig of the deleted region
(Murty et al. 1996). In the present study, in a continu-
ing effort to isolate the candidate gene, we assembled
an STS-content based cosmid, PAC, and BAC contig.
These smaller genomic clones serve as better reagents
for isolation of new STSs and ESTs and to generate a
complete sequence of the region. The STSs placed on
the previous YAC contig were used to screen genomic
libraries to identify corresponding cosmid, PAC, and
BAC clones by bidirectional chromosome walking.
The high-resolution physical map of the 12q22 re-
gion generated in this study spans ~ 3 Mb with com-
plete coverage of the minimal region of deletion in
male GCTs. This map represents a better resource for
identification of the candidate TSG in several ways.
The clones in the map provide substrates for genera-
tion of new polymorphic markers by screening for re-
peat sequences. In fact, we have identified one such
informative marker that mapped in the minimal de-
leted region, which allowed us to narrow the previ-
ously identified 1.7-Mb minimal deletion to 830 kb.
Availability of additional highly polymorphic markers
may allow further reduction in size of the minimal
deletion and simplify positional cloning efforts. The
contig permits an accurate placement of new genes
and ESTs on the map by PCR. To date, we have mapped
13 ESTs including five genes (HAL, ELK3, TMPO, PHC,
and APAF1), all outside the minimal deleted region.
The TMPO (Harris et al. 1995), PHC (Marsh et al. 1995),
and APAF1 (Zou et al. 1997) genes have been mapped
outside at the distal border, whereas HAL (Suchi et al.
1995) and ELK3 (Giovane et al. 1994, 1995) lie proxi-
mal to the minimal deletion. We have previously ex-
cluded TMPO as a target candidate TSG (Murty et al.
1996). The genomic structure of APAF1 has been char-
acterized and its role in GCTs is under investigation (S.
Bala, H. Oliver, B. Renault, K. Montgomery, S. Dutta, P.
Figure 1 Integrated physical map of the 12q22 deleted region in male GCTs. The map between the interval SHGC-33859 (proximal)
and D12S1100 (distal) is composed of 42 previously mapped YACs and 168 BACs, 49 PACs, and 52 cosmids isolated in this study. The
solid green bar (top) represents the chromosomal region in proximal to distal orientation. The markers ordered on the contig are shown
above the green bar (distances in the map are not to scale). All markers shown in green and P382A8/AG (shown in black) were generated
in this study by sequencing ends of the clones. Markers are color-coded as follows: (blue and green) nonpolymorphic; (red) EST/gene;
(black) polymorphic. Red brackets above the markers indicate that the ESTs are in the same unigene cluster. Small black brackets above
the green line indicate that the relative order of the markers could not be determined unambiguously. The numbers below the green line
indicate the genetic map position on chromosome 12 (Ge´ne´thon map). The first level of the map below the green line represents YACs
(black lines); the second level (below the YAC contig) represents BAC, PAC, and cosmid clone contig. The prefix B denotes BACs (black),
P denotes PACs (green), and c denotes cosmids (blue). The STS content of each clone is indicated by symbols: (black circle) polymorphic
marker; (blue square) nonpolymorphic marker; (blue square with red border) clone-end marker generated by sequencing; (downward red
triangle) EST; (upward red triangle) gene; (upward red triangle with blue border) gene sequence identified from an end sequence. Open
symbols indicate that the marker was not tested. A bracket within YAC or BAC clone indicates lack of marker(s), which may represent
internal deletion. The large bidirectional arrow (top) indicates the minimal region of deletion. BAC clones drawn in thick, black lines
represent minimal tiling path. Underlined clones indicate fingerprinted clones.
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Table 1. STSs and ESTs Mapped in the Present Study











D12S1716 AFMa065yd5 — GDB
D12S377 GATA4AO6 — GDB




D12S1051 GATA24A01 — GDB
D12S1657 AFMb293ye5 — GDB
— P382A8/AG (F)AAGACCCCAGACCCAATGTA this study (AQ254947)
(R) TCTGTCACCAACACTCACTGC
D12S1671 AFMb328xc5 — GDB
D12S393 GATA15AO3 — GDB
D12S1300 GATA85A04 — GDB





— B529N20/T7 (F) CCAAGGAACCCACAGAGTTT this study (AQ254896)
(R) GAAGCATTCTCAATTCCCCA
— P527I20/SP6 (F) GTTGCACCATCCTTCCTGAC this study (AQ254931)
(R) CACCACCCAGTGGAAACATT
— P527I20/T7 (F) CTGGAGTCCGAAATGTTGGT this study (AQ254932)
(R) AACTCCACTGGAAGAAGGCA
— P79B19/SP6 (F) CGCAATTTTCCTCCCATAAA this study (AQ254933)
(R) CCTGAATCCTGGCATCTTCT
— P192I14/SP6 (F) AAGGGATATTTTCAGTCCTCCC this study (AQ254934)
(R) TCACACAGCAATGTGAATGC
D12S1986 WI-9896 — WI-MIT/RH
— P328A10/T7 (F) ATACTCACAGCGCACGCTCT this study (AQ254935)
(R) ATGAGCTTTCCCTTGCTTTG
D12S1982 WI-9769 —
— P79B19/T7 (F) TGAAGTTCCACCACTCATATCC this study (AQ254936)
(R) CTTGGTTTGCTGAGACCACA
— B29A15/T7 (F) ATTTGGGACCTTATCCAGGG this study (AQ254897)
(R) GCCCTTCACCAATGACAGAT
— P328A10/SP6 (F) GTGACACCTGACGGGGTAGT this study (AQ254937)
(R) AGGAAGGAGTAGCAGGCACA
— P396O21/T7 (F) TGCGATGGGTTTTAACTTCC this study (AQ254938)
(R) ACCAAAACCCCATCTGTACG
— B29A15/SP6 (F) CGACTGATTCGCTATGGACA this study (AQ254898)
(R) AGCACATCTGCCTGAAACCT
— B421J7/T7 (F) AGAGAACAAGGTGCTTCCCA this study (AQ254899)
(R) GAGAGACTGGCTTCCTGGTG
— B60C14/SP6 (F) TGCAGAAATGGCACCTAACA this study (AQ254900)
(R) TTGAATCCCGGAGAAGGTAA
— B9L10/T7 (F) GCAGCCTCTCAGGATACCAG this study (AQ254901)
(R) GGCAGCTCCTCATTTCTCAG
— B60C14/T7 (F) GGAATTCTGCCTCCAGATTG this study (AQ254902)
(R) CACACAGAGAGGCTGAGAG
— B397H6/SP6 (F) TCGCATCTTAGGCTCACAAA this study (AQ254903)
(R) TCAGGATCTCCATGCTCAAG





D12S1280 952b1-R — AECOM/GDB





Table 1. (Continued )
Locus Clone/gene Primer sequence (5*–3*)
Source
(GenBank acc. no.)
— B397H6/T7 (F) GCTTTGGTTTTTGTGCATGA this study (AQ254904)
(R) GAAAGGCCATTTCAAGGGTT
— P140E4/T7 (F) AGAGTCTGAGGAACGGAAA this study (AQ254941)
(R) ATCTCGAGAAATCCTTGAGGTG
— c55A7/T3 (F) ACAGGGATGTGGCAAGATGT this study (AQ254954)
(R) AAGGAGGAAGAAAACACGGG
D12S1442 WI-4038 — GDB
— c55A7/T7 (F) TTGGCCATTACGTGGAAAAT this study (AQ254955)
(R) TCTGCATCAAAACCTTTCCC
— P251K18/T7 (F) AATCCATTGCTTCTGGGACTG this study (AQ254942)
(R) CTGACCTTTCAAGAATGCATCTG
— P373A17/T7 (F) TCTCTGCCTTTGCAAATCCT this study (AQ254943)
(R) TTTGGACAACAAGAGACAAACG
— P382A8/T7 (F) AACAGGCACAGGAAATCCAA this study (AQ254944)
(R) AATGGTGCACCTTCCCAATA
D12S1430 WI-3193 — GDB
— P251K18/SP6 (F) TTACCTGTATTTTCTGCACCCA this study (AQ254945)
(R) CAATACTATGGGCAGAGCCTT
— P373A17/SP6 (F) CCCAACTCTTTGAGGCCATA this study (AQ254946)
(R) TTTCAATCCGTTCCGTTTTC
— B492N15/T7 (F) CCCTGCCTCCTATGCTACTT this study (AQ254905)
(R) GCTGCATGGCATTCTACAGT
— B40P8/T7 (F) ACGCATTTCCAGGAGACATC this study (AQ254906)
(R) CTGGGGCAGAGAATATCCAA
— P382A8/SP6 (F) TGCAGTGAGTGTTGGTGACA this study (AQ254947)
(R) GAGATATTGATGCCCTGGGA
— B145P2/T7 (F) TTCAAGTGTGCTTCCTGCAC this study (AQ254907)
(R) TGGCCCCTTCTTAGTTGATG
D12S1279 781b3-L — AECOM/GDB
— P149C9/T7 (F) CAGGGCTCCTGAATGTTTGT this study (AQ254948)
(R) AATCATACCTCTCCCTGGGC
— P87E22/T7 (F) CCCCTTACCCCCAATTAAAA this study (AQ254949)
(R) AGTGTTGTGGCAAAGGGAAC
— B335G6/T7 (F) GCAAATGCCAACACAGCTTA this study (AQ254908)
(R) GAAGACCTATGCCCCAGGAT
— P813O21/T7 (F) GAGGCCATTACCCTTAGCAA this study (AQ254950)
(R) TTCATCCCCAAATACCAAGC
— B134G6/T7 (F) ATGTTCCTTGCTGGAAGCTC this study (AQ254909)
(R) TCTTGGTTTCCATGAGGAGG
— B145P2/SP6 (F) AACCTCTGAAGCAGACCAACA this study (AQ254910)
(R) TCTCATCAAGGAAAAATTCCAAA
— B757E18/SP6 (F) TAGACCGACATAAGCAGGGC this study (AQ254911)
(R) ATCAGAAGCTGTTCATCGCC
— B335G6/SP6 (F) TGACCTTCCATTTCCCTGAG this study (AQ254912)
(R) AAAGGAAAGGTTGGCAAGGT
— B552H16/T7 (F) GGCTTGGCACTTTGTCTTTT this study (AQ254913)
(R) GCATTGAAGGAAGGGATGTC
— B757E18/T7 (F) AAGGGGAAGGCATCCTTAGA this study (AQ254914)
(R) CAGACAGCTGCTTACCTCCC
— B66A22/T7 (F) GCTGCATCACTCTGTTTCCA this study (AQ254915)
— (R) CAGGTAAAAATGGGAAGGCA
— B499O14/SP6 (F) CCCCAGCAAATGTTCCTCTA this study (AQ 254916)
(R) AAGGCATTGGGTTAGTGCTG
— B552H16/SP6 (F) CTCCAACATGGTCCAGATCC this study (AQ254917)
(R) ACCCTTCCAAGGTAAGGCTC
— B428H10/T7 (F) GGAGCTCAAGCATCTTACGG this study (AQ254918)
(R) GGGATTAGCCATTGAGGGAT
— B1006M13/T7 (F) TAACAGCCCCTTGGAACATC this study (AQ254919)
(R) GGTGAGTTGGTTGAATGGCT
— B66A22/SP6 (F) TTGGGGGTGCTATCTTATGC this study (AQ254920)
(R) GGAGAGGGATGAGTTGGTGA
— B499O14/T7 (F) TCAAGGAGAGAATGTTGCCA this study (AQ254921)
(R) CAGTGGCACTAGGGAAGATGA
— B428H10/SP6 (F) GAAACAGCGACAGCATGAAA this study (AQ254922)
(R) TCTGATCTGTGGAAGCATCG
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Rao, J. Houldsworth, G. Bosl, R. Kucherlapati, X. Wang,
et al., in prep.). EST WI-17759 maps within the mini-
mal deleted region and its analysis in relation to GCTs
is in progress. The clones in the region provide excel-
lent resource for sequencing, exon trapping, and cDNA
selection. A set of BAC clones in the minimal tiling
path is being sequenced at the Genome Sequencing
Center at Baylor College of Medicine (see http://
sequence.aecom.yu.edu/chr12/).
The present map represents the most comprehen-
sive and accurate map of the 12q22 region currently
available. It contains 99 markers with an average
marker resolution of 30 kb whereas the Whitehead In-
stitute’s Radiation Hybrid map (WI-RH) and Stanford
RH map (Stewart et al. 1997) contains only 13 and 11
markers, respectively, within this interval. Only 4
markers are shared between WI-RH and Stanford RH
maps. Of the 13 markers in the WI-RH map, 11 are
identified in our map whereas our map shares only six
markers with the Stanford RH map. The order of mark-
ers is the same in our map and the Stanford map, ex-
cept that we could not resolve the order of D12S393
and D12S1300. The WI-RH map and our map have two
discrepancies. Our map placed SHGC-34081 proximal
to WI-10093, whereas the order in the WI-RH map is
reversed, and we mapped WI-11271 distal to
Table 1. (Continued )
Locus Clone/gene Primer sequence (5*–3*)
Source
(GenBank acc. no.)
— B1006M13/SP6 (F) AAGGGGATTCAGTGGTCAAA this study (AQ254923)
(R) CTGGTAGTCCCATAGGATTTAATTG
— B838B18/T7 (F) TGCCTTCCTCTCTACCAGGA this study (AQ254924)
(R) CTCTAGGGGCAACAACTTGG
— B15C22/T7 (F) CTGATGAGGGGCTAAAGCTG this study (AQ254925)
(R) AGGGTTAAATCCAGGTTGGG
— B152G17/SP6 (F) CAGCATGAACTCTTCCTGACC this study (AQ254926)
(R) CATGGTACAAAATGGTCCCG
— B743G1/T7 (F) CAGCCAATCAGTGATGCAGT this study (AQ254927)
(R) CTGCCTGTGGAGTACCCATT
— P424B14/SP6 (F) TGCCATTTATTCCCGAAGAG this study (AQ254951)
(R) CTGCTCCTTTTTCATCCCTG
— B15C22/SP6 (F) TTTTGTTCCAGAAACCCAGG this study (AQ254928)
(R) AAAGCCAGAGACGGTTTCAA
D12S1849 SHGC-13025 — GDB
— B152G17/T7 (F) AGCCTGACAAATGCCTCAGT this study (AQ254929)
(R) AGCCTGACAATTCTAGGGTCA
— B447K16/SP6 (F) CAGGCAAACTACCTACCCCA this study (AQ254930)
(R) AGATCAATCGCCTCTCTCCA
— P373G19/T7 (F) TCCCTCTGCTGTTAGCTTCC this study (AQ254952)
(R) TCTTCAGTTTCCATGTCCCA
D12S1098 681g7-L — GDB
— P373G19/SP6 (F) CCTCTGGTGATTGCAAGGAT this study (AQ254953)
(R) GTCGTGTATCAAAAACCGGG
D12S1082 WI-1945 — GDB
D12S1100 850b8-R — AECOM/GDB
ESTs
SGC33859 HAL — GDB
SGC34081 EST192317 — GDB
WI-10093 EST151358 — GDB
NIB1262 T16410 — GDB
WI-17759 — — GDB
WI-11271 TMPO — GDB
D29485 EST77185 — GDB
D12S1218E cda1fhO2 — GDB
Genes
HAL — — AECOM/GDB
ELK3 Z36715 (F) ACGTCTGGCCACAATTAAGG this study
(R) TGTCCTTCTCACGACACAGG
TMPO — — Harris et al. (1995)
PHC — — Marsh et al. (1995)
APAF1 — — Zou et al. (1997)
(AECOM) Albert Einstein College of Medicine; (APAF1) apoptosis protease activating factor 1; (ELK3) ETS-domain protein; (GDB)
human Genome Database; (CHLC) The Cooperative Human Linkage Center; (WI-MIT/RH) Whitehead Institute Radiation Hybrid map;





D12S1300/D12S393, whereas the WI-RH map placed it
proximal to these markers. The order of the markers in
our map is likely to be accurate as it is based on STS
content mapping.
LOH analysis of GCTs performed in the present
study enabled us to further refine the region of com-
mon deletion at 12q22 by the use of the additional
polymorphic markers P383A8-AG and D12S1671.
Based on LOH analysis utilizing these two markers,
four tumors (T-225A, T-225B, T-167A, and T-320A) re-
tained heterozygosity at markers D12S1671 and
P382A8-AG in the distal half of the previously de-
scribed region of minimal deletion. Thus, the refined
minimal deletion spans four polymorphic markers
(D12S377, GCT8B07, D12S1051, and D12S1657) com-
pared to nine markers that spanned the previously de-
fined minimal deletion, reducing it to approximately
half the size (Murty et al. 1996). The region of chro-
mosome 12q22 also demonstrated high frequency of
LOH in a variety of other tumors such as pancreatic
(Seymour et al. 1994; Hahn et al. 1995; Kimura et al.
1996, 1998) and gastrointestinal (Fey et al. 1989;
Schneider et al. 1995) carcinomas. Our physical map
provides valuable reagents for the positional cloning of
candidate genes involved in these tumors if different
from the one in GCT.
Taken together, the availability of high-resolution
cosmid, PAC, and BAC map and the refined interval of
minimal deletion containing the candidate TSG pro-
vides a basis for isolation of the gene at 12q22 region in
GCTs. The map will further allow the identification of
other novel genes present within this interval. METHODS
Identification of Cosmid, PAC, and BAC Clones
We previously identified 53 overlapping YACs in a contiguous
map of the12q22 region covering a 4-cM genetic distance
(Murty et al. 1996). This YAC contig served as a framework
map to generate a smaller genomic clone contig comprised of
cosmids, PACs, and BACs. In the present study, two human
chromosome 12 cosmid libraries (LL12NCO1 and
LL12NCO2) (Montgomery et al. 1993), human genomic PAC
(RPCI-1, RPCI-3, RPCI-4, RPCI-5) (Ioannou et al. 1994), and
BAC (RPCI-11) libraries obtained from Roswell Park Cancer
Institute (provided by Pieter de Jong) were used. High-density
gridded filters were hybridized with pooled PCR probes gen-
erated from nonpolymorphic markers and ESTs (Table 1). The
probes were generated by PCR of YAC DNA known to contain
the markers. They were gel-purified and 100 ng of each probe
were labeled with [a-32P]dCTP by random priming. The
probes were pooled together and hybridized to the high-
density filters after suppression with Cot1 DNA at 65°C fol-
lowing standard methods. Positive clones were identified on
autoradiograms and picked from library plates. All clones
were grown in Luria broth or 2 2 YT medium in 5 ml of
culture, and DNA was isolated by an alkaline lysis procedure.
YAC clones were grown in acid-hydrolyzed casein (AHC) me-
dium for two days at 30°C and DNA was prepared by the
standard mini-preparation method (Krauter et al. 1995). The
DNAs were tested by PCR for the presence of individual STS/
ESTs used for hybridization, initially on pools, and then on











D12S81 108 67 19 28
D12S379 108 79 27 34
D12S101 106 57 19 33
D12S309 108 79 24 30
D12S2087 106 57 22 39
D12S2085 108 70 31 44
D12S1716 107 59 29 49
D12S377 107 72 28 39
GCT8B07 102 29 10 34
D12S1051 107 86 38 44
D12S1657 108 58 26 45
P382A8-AG 98 79 25 32
D12S1671 105 71 21 30
D12S1300 106 68 31 46
D12S393 108 69 30 43
D12S296 104 63 25 40
D12S346 105 82 26 32
D12S58 107 63 20 32
D12S234 98 69 16 23
D12S367 107 82 19 23
D12S392 107 75 21 28
Figure 2 Identification of minimal deleted region at 12q22 by
LOH analysis in male GCTs. (A) G-banded ideogram of chromo-
some 12 and the corresponding 12q22 deleted region identified
by previous studies (Murty et al. 1992, 1996). (B) Physical map
order depicting polymorphic markers used in LOH analysis from
centromeric (left) to telomeric (right) orientation. The numbers
below indicate the genetic distances on chromosome 12 (Ge´ne´-
thon map; Dib et al. 1996). (C) Pattern of LOH in eight tumors
that define the minimal deleted region. Tumor numbers are
shown at left. Solid lines indicate region of retention of hetero-
zygosity; shaded lines indicate region of LOH. The boxed region
indicates the consensus minimal region of deletion (for definition,
see Methods).
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members of positive pools testing with individual markers.
Such analysis permitted conversion of the YAC contig map to
a cosmid, PAC, and BAC map. End sequences of the clones
were obtained using T3, T7, or SP6 vector-end sequencing
primers and dye-terminator sequencing. The sequences gen-
erated from clone ends were used to search the public data-
bases to identify homology with existing sequences and to
identify unique sequences. New nonpolymorphic STSs were
designed from the unique sequences using Primer 3 program
from the Whitehead Institute’s web site (http://www-
genome.wi.mit.edu/). These STSs were used for the next
round of screening of cosmid, PAC, and BAC filters. Several
rounds of library screening were performed to complete the
map.
Isolation of New STSs and Construction
of Cosmid/PAC/BAC Clone Contig
All newly identified cosmid, PAC, and BAC clones were first
confirmed by PCR for their position in the YAC framework
map by using the original primers for the STS/EST marker.
Once the map position of a new clone was confirmed, the
ends were sequenced, primers were designed, and STSs were
generated as described above (Table 1). Optimal PCR amplifi-
cation conditions were tested for each set of new STS and EST
primers. The STSs that amplified poorly or resulted in non-
specific PCR products, as well as the clones whose positions
could not be readily established, were excluded from the map.
The STS-content mapping was performed on appropriately
diluted (10- to 100-fold) clone DNAs by PCR in a final volume
of 10 µl using AmpliTaq DNA polymerase (Perkin-Elmer, Fos-
ter City, CA) by standard methods and the products were run
on 2% agarose gels stained with ethidium bromide. ESTs
mapped in the interval of the YAC contig were identified from
the public databases (Schuler et al. 1996; Genome Maps 7,
National Center for Biotechnology Information; Integrated
Map of Whitehead Institute; RH consortium map of Genome
Data Base) (Table 1) and obtained from Research Genetics
(Huntsville, AL). All positive clones were also tested for adja-
cent loci by STS content analysis. Overall, all clones were
tested for STS content of all markers in the contig either as
pools or as individual clones, and the resulting data were ana-
lyzed manually. In order to confirm the integrity of the clones
in the contig, a DNA fingerprint was generated. A redundant
set of clones was selected and grown in 5 ml culture, DNA was
prepared as above, and 100–500 ng of DNA was digested with
HindIII and electrophoresed on 1.0% agarose gel in TAE buffer
for 22 hr at 70 V as described (Marra et al. 1997; Renault et al.
1997). The gel was stained with SYBR Green (FMC Bioprod-
ucts, ME) and the image was scanned by the Molecular Dy-
namics FT595 fluorimager. The images were visually reviewed
to ascertain magnitude of overlap between and adjacent
clones in the contig and to rule out gross rearrangements.
Tumor and Normal DNA
Tumor tissues and the corresponding normal cells were ob-
tained, after informed consent, from patients with GCTs
evaluated at the Memorial Sloan-Kettering Cancer Center as
described (Murty et al. 1996). A total of 108 normal-tumor
DNAs derived from 97 patients were utilized for the LOH stud-
ies. Of these, eight were analyzed as cell lines and their deri-
vation was reported previously (Murty et al. 1996). All histo-
logic types (seminomatous and nonseminomatous), sites of
presentation, as well as primary and metastatic states, were
represented in the study.
Analysis of LOH
A total of 21 microsatellite markers were utilized in the LOH
analysis. These include 18 previously used markers (Murty et
al. 1996) and 3 additional markers (GCT8B07, D12S1671, and
P382A8-AG) including one isolated in the present study
(Table 1). PCR amplification, electrophoresis, and analysis of
LOH were performed as described previously (Murty et al.
1996). The criterion applied to define consensus minimal de-
letion was that the markers mapped in that interval exhibit
LOH in all tumors with retention of heterozygosity of proxi-
mal and distal makers in at least two different cases.
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